{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:54:35Z","timestamp":1784001275273,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bioorg.2023.106979","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T22:03:49Z","timestamp":1700345029000},"page":"106979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The discovery of a new potent FXR agonist based on natural product screening"],"prefix":"10.1016","volume":"143","author":[{"given":"Zongwen","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fancheng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bioorg.2023.106979_b0005","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41574-019-0266-7","article-title":"Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs","volume":"15","author":"Ahmad","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106979_b0010","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106979_b0015","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/bph.14126","article-title":"Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo","volume":"175","author":"Yang","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106979_b0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"24","key":"10.1016\/j.bioorg.2023.106979_b0025","doi-asserted-by":"crossref","first-page":"17545","DOI":"10.1021\/acs.jmedchem.1c01017","article-title":"Recent advances in the medicinal chemistry of farnesoid x receptor","volume":"64","author":"Fang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106979_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115307","article-title":"Machine learning- and structure-based discovery of a novel chemotype as FXR agonists for potential treatment of nonalcoholic fatty liver disease","volume":"252","author":"Qin","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2023.106979_b0035","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1021\/acs.jmedchem.3c00456","article-title":"Discovery of HPG1860, a structurally novel nonbile acid FXR agonist currently in clinical development for the treatment of nonalcoholic steatohepatitis","volume":"66","author":"Mo","year":"2023","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106979_b0040","doi-asserted-by":"crossref","first-page":"S925","DOI":"10.1016\/S0016-5085(19)39277-7","article-title":"Comparative effects of BAR502, a dual FXR and GPBAR1 agonist, obeticholic acid and ursodeoxycholic acid in a rodent model of NASH","volume":"156","author":"Carino","year":"2019","journal-title":"Gastroenterology."},{"key":"10.1016\/j.bioorg.2023.106979_b0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.phrs.2018.02.033","article-title":"Disruption of TFG\u03b2-SIVIAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand","volume":"131","author":"Carino","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106979_b0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/13543776.2018.1459569","article-title":"Farnesoid X receptor modulators 2014-present: a patent review","volume":"28","author":"Sepe","year":"2018","journal-title":"Expert Opin. Ther. Patents."},{"issue":"17","key":"10.1016\/j.bioorg.2023.106979_b0055","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/jm025529g","article-title":"6 alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity","volume":"45","author":"Pellicciari","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106979_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112910","article-title":"Structure-guided modification of isoxazole-type FXR agonists: Identification of a potent and orally bioavailable FXR modulator","volume":"209","author":"Luo","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106979_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111652","article-title":"Highly potent non-steroidal FXR agonists protostane-type triterpenoids: structure-activity relationship and mechanism","volume":"182","author":"Luan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106979_b0070","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1021\/jacsau.2c00600","article-title":"Biomimetic total synthesis and the biological evaluation of natural product (-)-fargesone A as a novel FXR agonist","volume":"2","author":"Guo","year":"2022","journal-title":"JACS Au."},{"issue":"B","key":"10.1016\/j.bioorg.2023.106979_b0075","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.ijbiomac.2020.10.029","article-title":"PL-S2, a homogeneous polysaccharide from Radix Puerariae lobatae, attenuates hyperlipidemia via farnesoid X receptor (FXR) pathway-modulated bile acid metabolism","volume":"165","author":"Rao","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106979_b0080","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1021\/acs.orglett.7b01276","article-title":"Xylopiana A, a dimeric guaiane with a case-shaped core from Xylopia vielana: structural elucidation and biomimetic conversion","volume":"19","author":"Zhang","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2023.106979_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104646","article-title":"Dimeric guaianes from leaves of Xylopia vielana as snail inhibitors identified by high content screening","volume":"108","author":"Xu","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106979_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.03.065","article-title":"Vieloplains A-G, seven new guaiane-type sesquiterpenoid dimers from Xylopia vielana","volume":"88","author":"Xie","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106979_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105072","article-title":"Artematrovirenins A-P, guaiane-type sesquiterpenoids with cytotoxicities against two hepatoma cell lines from Artemisia atrovirens","volume":"114","author":"Su","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106979_b0100","doi-asserted-by":"crossref","first-page":"e1900013","DOI":"10.1002\/cbdv.201900013","article-title":"Sesquiterpenes from the leaves of Magnolia delavayi Franch. and their cytotoxic activities","volume":"16","author":"Xie","year":"2019","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2023.106979_b0105","first-page":"2512","volume":"21","author":"Srikrishna","year":"2010","journal-title":"Enantiospecific First Total Synthesis and Confirmation of the Relative and Absolute Stereostructure of Isocalamusenone"},{"issue":"8","key":"10.1016\/j.bioorg.2023.106979_b0110","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1248\/cpb.16.1605","article-title":"Structure of Procurcumenol","volume":"16","author":"Hikino","year":"1968","journal-title":"Chem. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106979_b0115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1445-6664.2005.00186.x","article-title":"Plant growth inhibitors: patchoulane-type sesquiterpenes from Cyperus rotundus L","volume":"5","author":"Morimoto","year":"2005","journal-title":"Weed Biol. Manage."},{"issue":"10","key":"10.1016\/j.bioorg.2023.106979_b0120","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/S0031-9422(00)82666-7","article-title":"Sesquiterpenes from Japanese liverworts","volume":"20","author":"Toyota","year":"1981","journal-title":"Phytochemistry"},{"issue":"6","key":"10.1016\/j.bioorg.2023.106979_b0125","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1021\/np200181d","article-title":"Positive gabaa receptor modulators from Acorus calamus and structural analysis of (+)-dioxosarcoguaiacol by 1D and 2D NMR and molecular modeling","volume":"74","author":"Zaugg","year":"2011","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106979_b0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/np900506g","article-title":"Cytotoxic triterpene dilactones from the stems of Kadsura ananosma","volume":"73","author":"Yang","year":"2010","journal-title":"J. Nat. Prod."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106979_b0135","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1248\/cpb.55.594","article-title":"Terpenoid-related metabolites from a Formosan soft coral Nephthea chabrolii","volume":"55","author":"Su","year":"2007","journal-title":"Chem. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106979_b0140","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1021\/np8003062","article-title":"ent-kaurane diterpenoids from the liverwort Jungermannia atrobrunnea","volume":"71","author":"Qu","year":"2008","journal-title":"J. Nat. Prod."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106979_b0145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0031-9422(79)80070-9","article-title":"New sesquiterpenoids of sweet flag oil (Acorus calamus)","volume":"18","author":"Rohr","year":"1979","journal-title":"Phytochemistry"},{"issue":"14","key":"10.1016\/j.bioorg.2023.106979_b0150","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1055\/s-2007-990247","article-title":"Diterpenoids from the roots of Croton oblongifolius","volume":"73","author":"Youngsa-Ad","year":"2007","journal-title":"Planta Med."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106979_b0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jep.2015.05.040","article-title":"Bioactivity-guided isolation of anti-hepatitis B virus active sesquiterpenoids from the traditional chinese medicine: rhizomes of Cyperus rotundus","volume":"171","author":"Xu","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106979_b0160","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1021\/jm400419e","article-title":"Binding mechanism of the farnesoid X receptor marine antagonist suvanine reveals a strategy to forestall drug modulation on nuclear receptors. design, synthesis, and biological evaluation of novel ligands","volume":"56","author":"Di Leva","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106979_b0165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/164_2019_234","article-title":"Structural insight into the binding mode of FXR and GPBAR1 modulators","volume":"256","author":"Di Leva","year":"2019","journal-title":"Handb Exp. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106979_b0170","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1021\/jm401873d","article-title":"Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors","volume":"57","author":"D'Amore","year":"2014","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2023.106979_b0175","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1016\/j.bmcl.2008.06.073","article-title":"Conformationally constrained farnesoid X receptor (FXR) agonists: naphthoic acid-based analogs of GW 4064","volume":"18","author":"Akwabi-Ameyaw","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106979_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113803","article-title":"Effects of Sedi Herba (Sedum sarmentosum) on attenuating cholestasis by the activation of the farnesoid x receptor (FXR)-mediated signaling","volume":"155","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106979_b0185","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.apsb.2021.05.023","article-title":"Bile acid homeostasis in female mice deficient in Cyp7a1 and Cyp27a1","volume":"11","author":"Rizzolo","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.bioorg.2023.106979_b0190","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1021\/acs.jmedchem.9b01621","article-title":"Nidufexor (LMB763), a novel FXR modulator for the treatment of nonalcoholic steatohepatitis","volume":"63","author":"Chianelli","year":"2020","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106979_b0195","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.bbadis.2017.09.019","article-title":"Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations","volume":"1864","author":"Cariello","year":"2018","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"10.1016\/j.bioorg.2023.106979_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114903","article-title":"Structural optimization and biological evaluation of 1-adamantylcarbonyl-4-phenylpiperazine derivatives as FXR agonists for NAFLD","volume":"245","author":"Qin","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106979_b0205","doi-asserted-by":"crossref","unstructured":"H. Hussain, I. Ali, D. Wang, N.Z. Mamadalieva, W. Hussain, R. Csuk, A. Loesche, L. Fischer, D. Staerk, S. Anam, M.N. AlZain, M. Mushtaq, Z. Ul-Haq, R. Ullah, O.M. Noman, G. Abbas, I.R. Green, 4-Benzyloxylonchocarpin and muracatanes A-C from Ranunculus muricatus L. and their biological effects, Biomolecules. 10 (11) (2020) 1562.","DOI":"10.3390\/biom10111562"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106979_b0210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bcp.2014.09.009","article-title":"Alisol B 23-acetate promotes liver regeneration in mice after partial hepatectomy via activating farnesoid X receptor","volume":"92","author":"Meng","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106979_b0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.phrs.2017.04.021","article-title":"Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling","volume":"121","author":"Gu","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.bioorg.2023.106979_b0220","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1016\/j.apsb.2022.06.013","article-title":"Schisandrol A protects AGEs-induced neuronal cells death by allosterically targeting ATP6V0d1 subunit of V-ATPase","volume":"12","author":"Zhou","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"9","key":"10.1016\/j.bioorg.2023.106979_b0225","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.apsb.2021.03.011","article-title":"Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation","volume":"11","author":"Lv","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106979_b0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cmet.2022.11.012","article-title":"Discovery of a potent allosteric activator of DGKQ that ameliorates obesity-induced insulin resistance via the sn-1,2-DAG-PKC\u03b5 signaling axis","volume":"35","author":"Zheng","year":"2023","journal-title":"Cell Metab."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823006405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823006405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:46:45Z","timestamp":1758617205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823006405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":46,"alternative-id":["S0045206823006405"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106979","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The discovery of a new potent FXR agonist based on natural product screening","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106979"}}